BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 24587388)

  • 1. Blood platelets in the progression of Alzheimer's disease.
    Gowert NS; Donner L; Chatterjee M; Eisele YS; Towhid ST; Münzer P; Walker B; Ogorek I; Borst O; Grandoch M; Schaller M; Fischer JW; Gawaz M; Weggen S; Lang F; Jucker M; Elvers M
    PLoS One; 2014; 9(2):e90523. PubMed ID: 24587388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet-Mediated Amyloid Aggregation in Alzheimer's Disease.
    Donner L; Feige T; Freiburg C; Toska LM; Reichert AS; Chatterjee M; Elvers M
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.
    Jarre A; Gowert NS; Donner L; Münzer P; Klier M; Borst O; Schaller M; Lang F; Korth C; Elvers M
    Cell Signal; 2014 Sep; 26(9):2040-50. PubMed ID: 24928203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of N-terminal residues for amyloid-β binding to platelet integrin α
    Donner L; Gremer L; Ziehm T; Gertzen CGW; Gohlke H; Willbold D; Elvers M
    Cell Signal; 2018 Oct; 50():121-130. PubMed ID: 29964150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release.
    Donner L; Fälker K; Gremer L; Klinker S; Pagani G; Ljungberg LU; Lothmann K; Rizzi F; Schaller M; Gohlke H; Willbold D; Grenegard M; Elvers M
    Sci Signal; 2016 May; 9(429):ra52. PubMed ID: 27221710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelets in the Alzheimer's disease brain: do they play a role in cerebral amyloid angiopathy?
    Kniewallner KM; Ehrlich D; Kiefer A; Marksteiner J; Humpel C
    Curr Neurovasc Res; 2015; 12(1):4-14. PubMed ID: 25557380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-fat diet-induced atherosclerosis promotes neurodegeneration in the triple transgenic (3 × Tg) mouse model of Alzheimer's disease associated with chronic platelet activation.
    Wang M; Lv J; Huang X; Wisniewski T; Zhang W
    Alzheimers Res Ther; 2021 Aug; 13(1):144. PubMed ID: 34454596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.
    Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM
    Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
    Solé M; Miñano-Molina AJ; Unzeta M
    Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
    Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model.
    Kim SH; Ahn JH; Yang H; Lee P; Koh GY; Jeong Y
    Acta Neuropathol Commun; 2020 Nov; 8(1):181. PubMed ID: 33153499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with five vascular risk factors causes cerebral amyloid angiopathy but no Alzheimer pathology in C57BL6 mice.
    Foidl BM; Humpel C
    Brain Behav Immun; 2019 May; 78():52-64. PubMed ID: 30664922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
    Wheeler KV; Irimia A; Braskie MN
    J Alzheimers Dis; 2024; 97(4):1479-1502. PubMed ID: 38306032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    Parodi-Rullán R; Sone JY; Fossati S
    J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.